Interleukin-4 and Cancer Therapy

References

• Howard M., Farrar J., Hilfiker M., et al. Identification of a T cell-derived B cell stimulatory factor distinct from IL-2. J Exp Med 1982; 155: 914–923
   PubMed Web of Science ®Google Scholar
• Isakson P. C., Pure E., Vitetta S., et al. T cell-derived B cell differentiation factor (s). Effect on the isotype switch of munne B cells. J Exp Med 1982; 155: 734–748
   PubMed Web of Science ®Google Scholar
• Noma Y., Sideras P., Naito T., et al. Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter. Nature 1986; 319: 640–646
   PubMed Web of Science ®Google Scholar
• Lee F., Yokoda T., Otsuka T., et al. Isolation and characterization of a mouse interleukin cDNA that expresses B-cell stimulatory factor 1 activities, and T cell and mast cell stimulating activities. Proc Natl Acad Sci USA 1986; 83: 2061–2065
   PubMed Web of Science ®Google Scholar
• Yokoda T., Otsuka T., Mosman T., et al. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, and that expresses B-cell and T cell stimulatory activities. Proc Natl Acad Sci USA 1986; 83: 5894–5898
   PubMed Web of Science ®Google Scholar
• Kuhn R., Rajewsky K., Muller W. Generation and analysis of interleukin-4 deficient mice. Science 1991; 254: 707–710
   PubMed Web of Science ®Google Scholar
• Tepper R. I., Levinson D. A., Stanger B. Z., et al. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 1990; 62: 457–466
   PubMed Web of Science ®Google Scholar
• Burnstein H. J., Tepper R. I., Leder P., et al. Humoral immune functions in IL-4 transgenic mice. J Immunol 1991; 147: 2950–2956
   PubMed Web of Science ®Google Scholar
• Brown M., Hu-Li J., Paul W. E. II-4/B-cell stimulatory factor-1 stimulates T cell growth by an IL-2 independent mechanism. J Immunol 1988; 131: 504–541
   Google Scholar
• Spits H., Yssel H., Takebe Y., et al. Recominant IL-4 promotes the growth of human T cells. J Immunol 1987; 139: 1142–1147
   PubMed Web of Science ®Google Scholar
• Martinez O. M., Gibbons R. S., Garovoy M. R., et al. IL-4 inhibits IL-2 receptor and IL-2 dependent proliferation of human T cells. J Immunol 1990; 144: 2211–2215
   PubMed Web of Science ®Google Scholar
• Kawakami Y., Rosenberg S. A., Lotze M. T. Interleukin 4 promotes the growth of tumor infiltrating lymphocytes cytotoxic for human autologous melanoma. J Exp Med 1989; 168: 2183
   Web of Science ®Google Scholar
• Horohov D. W., Crim J. A., Smith P. J., et al. IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell mediated immunity. J. Immunol 1988; 141: 4217–4223
   Web of Science ®Google Scholar
• Spits H., Yssel H., Takebe Y., et al. IL-4 inhibits IL-2-mediated induction of human lymphokine activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed lymphocyte cultures. J Immunol 1988; 141: 29–36
   PubMed Web of Science ®Google Scholar
• Yamashita U., Tanaka Y. Suppressive activity of intereleukin 4 on the induction of antigen-specific cytotoxic T cells in humans. Jpn J Cancer Res 1991; 82: 585–592
   PubMedGoogle Scholar
• Vercelli D., Jabara H. H., Lauener R. P., et al. IL-4 inhibits synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol 1990; 144: 570–573
   PubMed Web of Science ®Google Scholar
• Kawakami Y., Custer M. C., Rosenberg S. A., et al. IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. J Immunol 1989; 142: 3452–3461
   PubMed Web of Science ®Google Scholar
• Defrance T., Vandervliet B., Aubry J-P, et al. B cell growth promoting activity of recombinant human interleukin 4. J Immunol 1987; 139: 1135–1141
   PubMed Web of Science ®Google Scholar
• Banchereau J., DePaoli P., Valle A., et al. Long-term human B-cell lines dependent on interleukin-4 and antibody to CD40. Science 1991; 251: 70–72
   PubMed Web of Science ®Google Scholar
• Llorente L., Mitjavila F., Crevon M-C, et al. Dual effects of interleukin 4 on antigen activated human B cell: Induction of proliferation and inhibition of interleukin 2-dependent differentiation. Eur J Immunol 1990; 20: 1887–1892
   PubMed Web of Science ®Google Scholar
• Noelle R. J., Krammer P. H., Ohara J., et al. Increased expression of la antigens on resting B cells: An additional role for B cell growth factor. Proc Natl Acad Sci USA 1984; 81: 6149–6155
   PubMed Web of Science ®Google Scholar
• Lee H-K, Xia X., Choi Y. S. IL-4 blocks the up-regulation of IL-2 receptors induced by IL-2 in normal human B cells. J Immunol 1990; 69: 57–64
   Google Scholar
• Karray S., Dautry-Varsat A., Tsudo M., et al. IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells. J Immunol 1990; 145: 1152–1158
   PubMed Web of Science ®Google Scholar
• DeFrance T., Vandervliet B., Pene J., et al. Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM. J Immunol 1988; 141: 2000–2005
   PubMed Web of Science ®Google Scholar
• Jelinek D. F., Lipsky P. Inhibitory influence of IL-4 on human B cell responsiveness. J Immunol 1988; 141: 164–173
   PubMed Web of Science ®Google Scholar
• Karray S., DeFrance T., Merle-Beral H., et al. Interleukin 4 counteracts the IL-2 induced proliferation of monoclonal B cells. J Exp Med 1988; 168: 85–94
   PubMed Web of Science ®Google Scholar
• Gascan H., Gauchat J-F, Roncarolo M-G, et al. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J Exp Med 1991; 173: 747–750
   PubMed Web of Science ®Google Scholar
• Shields J. G., Armitage R. J., Jamieson B. N., et al. Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4. Immunology 1989; 66: 224–227
   PubMed Web of Science ®Google Scholar
• DeFrance T., Aubry J. PL, Rousset F., et al. Human recombinant IL-4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes. J Exp Med 1987; 165: 1459–1467
   PubMed Web of Science ®Google Scholar
• Butcher R. DJ, McGarvie G. M., Cushley W. Recombinant interleukin 4 promotes the expression of CD25 (tac) antigen at the plasma membrane of high density human tonsillar B lymphocytes. Immunology 1990; 144: 3431–3436
   Google Scholar
• Rousset F., Billaud M., Blanchard D., et al. IL-4 induces LFA-1 and LFA-3 on Burkitt's lymphoma cell lines. J Immunol 1989; 143: 1490–1498
   PubMed Web of Science ®Google Scholar
• Te Velde A. A., Klomp J. PG, Yard B. A., et al. Modulation of phe-notypic and functional properties of human peripheral blood monocytes by IL-4. J Immunol 1988; 140: 1548–1554
   PubMed Web of Science ®Google Scholar
• Essner R., Rhoades K., Me Bride W. H., et al. IL-4 down-regulates IL-2 and TNF gene expression in human monocytes. J Immunol 1989; 142: 3857–3861
   PubMed Web of Science ®Google Scholar
• Hart P. H., Vitti G. F., Burgess D. R., et al. Potential antiinflamma-tory effects of IL-4: Suppression of human monocyte TNF, IL-1 and PGE2. Proc Natl Acad Sci USA 1989; 86: 3803–3807
   PubMed Web of Science ®Google Scholar
• Standiford T. J., Strieter R. M., Chensue S. W., et al. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol 1990; 145: 1435–1439
   PubMed Web of Science ®Google Scholar
• Cheung D. L., Hart P. H., Vitti G. F., et al. Contrasting effects of interferon-gamma and interleukin-4 on the IL-6 activity of stimulated human monocytes. Immunology 1990; 71: 70–75
   PubMed Web of Science ®Google Scholar
• Weiser M., Bonifer R., Roster W., Lindemann A., Meltelsmann R., Hermann F. Interleukin 4 induces secretion of CSF for granulo-cytes and CSF for macrophages by peripheral blood monocytes. Blood 1989; 73: 1105–1108
   PubMed Web of Science ®Google Scholar
• Broxmeyer H. E., Lu L., Cooper S., Tushinski R., Mochizuki D., Rubin B. Y., Gillis S., Williams D. E. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. J Immunol 1988; 141: 3852–3862
   PubMed Web of Science ®Google Scholar
• TeVelde A. A., Huijbens R. JF, DeVries J. E., Figdor C. G. IL-4 decreased FcγR membrane expression and FcγR-mediated cytotoxic activity of human monocytes. J Immunol 1990; 144: 3046–3051
   PubMed Web of Science ®Google Scholar
• Hudson M. M., Markowitz A. B., Gutterman J. U., Knowles R. D., Sny-Der J. S., Kleinerman E. S. Effect of recombinant human IL-4 on human monocyte activity. Cancer Res 1990; 50: 3154–3158
   PubMed Web of Science ®Google Scholar
• Te Velde A. A., Klomp J. PG, Yard B. A., de Vries J. E., Figdor C. G. Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J Immunol 1988; 140: 1548–1554
   PubMed Web of Science ®Google Scholar
• Vercelli D., Jabara H. H., Lee B-W, Woodland N., Geha R. S., Leung D. YM. Human recombinant IL-4 induces FceR2/CD23 on normal human monocytes. J Exp Med 1988; 167: 1406–1416
   PubMed Web of Science ®Google Scholar
• Wong H. L., Lotze M. T., Wahl L. M., et al. Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes. J Immunol 1992; 148: 2118–2125
   PubMedGoogle Scholar
• Hart P. H., Burggess D. R., Vitti G. F., Hamilton J. A. IL-4 stimulates human monocytes to produce tissue-plasminogen activator. Blood 1989; 74: 1222–1225
   PubMed Web of Science ®Google Scholar
• Lewis D. B., Yu C. C., Forbush K. A., et al. Interleukin 4 expressed in-situ selectively alters thymocyte development. J Exp Med 1991; 62: 457–467
   Google Scholar
• Valenga E., de Wolf J. ThM, Baentjes J. AM, Esselink M. T., Smit J. W., Halie M. R. Divergent effects of IL-4 on the granulocye colony-stimulating factor and IL-3 supported myeloid colony formation from normal and leukemic bone marrow cells. Blood 1990; 75: 633–637
   PubMed Web of Science ®Google Scholar
• Jansen J. H., Wientjens G. JHM, Fibbe W. E., Willemze R., Kluin-Nelemans J. C. Inhibition of human macrophage-colony formation by IL-4. J Exp Med 1989; 170: 577–582
   PubMed Web of Science ®Google Scholar
• Mosman T. R., Bond M. W., Coffman R. L., Ohara J., Paul W. E. T cell and mast cell lines respond to B-cell stimulatory factor-1. Proc Natl Acad Sci USA 1986; 83: 5654–5658
   PubMed Web of Science ®Google Scholar
• Valent T., Bevec D., Maurer D., et al. IL-4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci USA 1991; 88: 339–342
   Google Scholar
• Howells G., Pham P., Taylor D., Foxwell B., Feldman M. IL-4 induces IL-6 production by endothelial cells: Synergy with interferon-γ. Eur J Immunol 1991; 21: 97–101
   PubMed Web of Science ®Google Scholar
• Thomhill M. H., Kyan-Aung U., Haskard D. O. IL-4 increased human endothelial cell adhesiveness for T cells but not for neutro-phils. J Immunol 1990; 144: 3060–3065
   PubMed Web of Science ®Google Scholar
• Thornhill M. H., Haskard D. O. IL-4 regulates endothelial cell activation by IL-1, TNF, of IFN-γ. J Immunol 1990; 145: 865–872
   PubMed Web of Science ®Google Scholar
• Masinovsky B., Urdal D., Gallatin W. M. IL-4 acts synergistically with IL-1 to promote lymphocyte adhesion to microvascular en-dothelium by induction of vascular cell adhesion molecule-1. J Immunol 1990; 145: 2886–2895
   PubMed Web of Science ®Google Scholar
• Toi M., Harris A. L., Bicknell R. IL-4 is a potent mitogen for capillary endothelium. Biochem Biophys Res Commun 1991; 174: 1287–1293
   PubMed Web of Science ®Google Scholar
• Boey H., Rosenbaum R., Jon Castracane B. A., et al. Interleukin 4 is a neutrophil activator. J Allergy Clin Immunol 1989; 83: 978–984
   PubMed Web of Science ®Google Scholar
• Fabre C., Saeland S., Caux C., et al. InterIeukin-4 has basophilic and eosinophilic cell growth-promoting activity on cord blood cells. Blood 1990; 75: 67–73
   PubMed Web of Science ®Google Scholar
• White M. V., Igarashi Y., Emergy B. E., et al. Effects of in vivo administration of IL-2 and IL-4, alone and in combination, on ex vivo human basophil histamine release. Blood 1992; 79: 1491–1495
   PubMed Web of Science ®Google Scholar
• Paul W. E. Interleukin-4: A prototypic immunoregulatory lym-phokine. Blood 1990; 77: 1859–1870
   Web of Science ®Google Scholar
• Ohara J., Coligan J., Koon K., et al. High efficiency purification and chemical characterization of B cell stimulatory factor 1/IL-4. J Immunol 1987; 139: 1127–1138
   PubMed Web of Science ®Google Scholar
• Grabstein K., Eiseman J., Mochizuki D., et al. Purification to homogeneity of B cell stimulating factor. J Exp Med 1986; 163: 1405–1414
   PubMed Web of Science ®Google Scholar
• Arai N., Nomura D., Villaret D., et al. Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J Immunol 1989; 142: 274–282
   PubMed Web of Science ®Google Scholar
• Mosman T. R., Yokota T., Kastelein R., et al. Species-specificity of T-cell stimulating activities of IL-2, BSF-1 (IL-4): Comparison of normal and recombinant, mouse and human IL-2 and BSF-1 (IL-4). J Immunol 1897; 138: 1813–1816
   Google Scholar
• Ohara J., Paul W. E. Receptors for B-cell stimulatory factor-1 expressed on cells of hematopoeitic lineage. Nature 1987; 325: 537–540
   PubMed Web of Science ®Google Scholar
• Park L. S., Friend D., Sassenfeld H. M., et al. Characterization of the human B cell stimulatory factor 1 receptor. J Exp Med 1987; 166: 476–488
   PubMed Web of Science ®Google Scholar
• Idzerda R. L., March C. J., Mosley B., et al. Human Interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 1990; 171: 861–873
   PubMed Web of Science ®Google Scholar
• Le H. V., Ramanathan L., Labdon J. E., et al. Isolation and characterization of multiple variants of recombinant human interleukin-4 expressed in mammalian cells. J Biol Chem 1988; 263: 10817–10823
   PubMed Web of Science ®Google Scholar
• Le Beau M. M., Lemons R. S., Espinoza R., III, et al. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors are deleted in myeloid leu-kemias with del (5q). Blood 1989; 73: 647–650
   PubMed Web of Science ®Google Scholar
• Takahashi M., Yoshida M. C., Satosh H., et al. Chromosomal mapping of the mouse IL-4 and human IL-5 genes. Genomics 1989; 4: 47–56
   PubMed Web of Science ®Google Scholar
• Van leeuween B. H., Martinson M. E., Wee G. C., et al. Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood 1990; 73: 350–356
   Google Scholar
• Otsuka T., Villaret D., Yokota T., et al. Structural analysis of the mouse chromosomal gene encoding interleukin 4 which expresses B cell, T cell and mast cell stimulating activities. Nucleic Acids Res 1987; 14: 333–244
   Google Scholar
• Eder A., Krafft-Czepa H., Krammer P. H. The 5′ region of the human interleukin 4 gene: structure and potential regulatory elements. Nucleic Acids Res 1988; 16: 772–779
   PubMed Web of Science ®Google Scholar
• Mossmann T. R., Cherwinski H., Bond M. W., et al. Two types of murine helper T cell clones. Definition according to profiles of lympokines activities and secreted proteins. J Immunol 1986; 136: 2348–2357
   PubMed Web of Science ®Google Scholar
• Howard M., Farrar J., Hilfiker M., et al. Identification of a T cell derived B cell growth factor distinct from interleukin 2. J Exp Med 1982; 155: 914–923
   PubMed Web of Science ®Google Scholar
• Milanese C., Richardson N. ER, Reinherz E. L. Identification of T helper cell-derived lymphokine that activates resting T lymphocytes. Science 1986; 231: 1118–1122
   PubMed Web of Science ®Google Scholar
• Plaut M., Pierce J. H., Watson C. J., et al. Mast cell lines produce lymphokines in response to cross lineage of FCεRI or to calcium ionophores. Nature 1989; 6219: 64–67
   Google Scholar
• Swain S. L., Zlotnik A., Woodward J. G. Characterization of T helper I and 2 cell subsets in normal mice. J Immunol 1988; 141: 3445–3455
   PubMed Web of Science ®Google Scholar
• Sideras P., Funa K., Zalcberg-Quintana I., et al. Analysis by in-situ hybridization of cells expressing mRNA for interleukin 4 in the developing thymus and in peripheral lymphocytes from mice. Proc Natl Acad Sci USA 1988; 85: 218–221
   PubMed Web of Science ®Google Scholar
• Ben-Sasson S. Z., Gros G. L., Conrad D. H., et al. IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production. J Immunol 1990; 145: 1127–1136
   PubMed Web of Science ®Google Scholar
• Seder R. A., Boulay J-L, Finkelman F., et al. CDS+ T cells can be primed in vitro to produce IL-4. J Immunol 1992; 148: 1652–1656
   PubMed Web of Science ®Google Scholar
• O'Garra A., Barbis D., Hirada N., et al. Constitutive production of lymphokines by cloned murine B-cell lymphomas:CH12 B lym-phoma produces interleukin 4. J Mol Cell Immunol 1989; 4: 149–158
   PubMedGoogle Scholar
• Paliard X., De Waal M. R., Yssel H., et al. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD+ and CD+ T cell clones. J Immunol 1988; 141: 849–855
   PubMed Web of Science ®Google Scholar
• Wierenga E. A., Snoek M., de Groot C., et al. Evidence for com-partmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol 1990; 144: 4651–4658
   PubMed Web of Science ®Google Scholar
• Tanaka Y., Saito K., Shirakawa F., et al. Production of B-cell stimulating factors by B cells in patients with systemic lupus erythe-matosus. J Immunol 1988; 141: 3043–3049
   PubMed Web of Science ®Google Scholar
• Chretien I., Van Kimmenade A., Pearce M. K., et al. Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin 4. J Immunol Methods 1989; 117: 67–81
   PubMed Web of Science ®Google Scholar
• Horohov D. W., Crira J. A., Smith P., Siegel J. P. IL-4 (B-cell stimulatory factor-1) regulates multiple aspects of influenza virus-specific cell mediated immunity. J Immunol 1988; 141: 4217–4223
   PubMed Web of Science ®Google Scholar
• Lewis D. B., Prickett K. S., Larsen A., et al. Restricted production of interleukin 4 by activated human T cells. Proc Natl Acad Sci USA 1988; 85: 9743–9747
   PubMed Web of Science ®Google Scholar
• van der Heijden F. L., Wierenga E. A., Bos J. D., et al. High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991; 97: 389–394
   PubMed Web of Science ®Google Scholar
• Salmon M., Kitas C. D., Bacon P. A. Production of lymphokine mRNA by CD45RA+ and CF45RA-helper T cells from human peripheral blood and by human CD4+ T cell clone. J Immunol 1989; 143: 907–912
   PubMed Web of Science ®Google Scholar
• Idzerda R. L., March C. J., Mosley B., et al. Human Interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 1990; 171: 861–873
   PubMed Web of Science ®Google Scholar
• Lowenthal J. W., Castle B. E., Christiansen J., et al. Expression of high affinity receptors for murine interleukin 4 (BSF-I) on he-matopoietic and nonhematopoietic cells. J Immunol 1988; 140: 456–464
   PubMed Web of Science ®Google Scholar
• Park L. S., Friend D., Sassenfeld H. M., et al. Characterization of the high affinity cell surface receptor for murine B cell stimulatory factor-1. Proc Natl Acad Sci USA 1987; 84: 1669–1673
   PubMed Web of Science ®Google Scholar
• Ohara J., Paul W. E. Upregulation of Interleukin 4/B cell stimulatory factor-1 receptor expression. Proc Natl Acad Sci USA 1988; 85: 8221–8225
   PubMed Web of Science ®Google Scholar
• Puri R. K., Finbloom D. S., Leland P., et al. Expression of high affinity IL4 receptors on murine tumor infiltrating lymphocytes and their upregulation by IL2. Immunology 1990; 70: 492–497
   PubMed Web of Science ®Google Scholar
• Puri R. K., Aggarwal B. B. Human immunodeficiency virus type I tat gene up-regulates interleukin 4 receptors on a human B-lymphoblastoid cell line. Cancer Res 1992; 52: 3787–3790
   PubMed Web of Science ®Google Scholar
• Foxwell B. MJ, Woerly G., Ruffel B. Identification of Interleukin 4 receptor-associated proteins and expression of both high and low-affinity binding on human lymphoid cells. Eur J Immunol 1989; 19: 1637–1641
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Beckmann M. P., Idzerda R. L., et al. Regulation of interleukin 4 receptors on human T cells. Int Immunol 1990; 2: 1039–1045
   PubMed Web of Science ®Google Scholar
• Zuber C., Galizzi J. P., Valle A., et al. Interleukin 4 receptors in normal human B lymphocytes: Characterization and regulation. Eur J Immunol 1990; 20: 551–555
   PubMed Web of Science ®Google Scholar
• Wagteveld A. J., Zanten A. KV, Esselink M. T., et al. Expression and regulation of IL-4 receptors on human monocytes and acute myeloblastic leukemia cells. Leukemia 1991; 5: 782–788
   PubMed Web of Science ®Google Scholar
• Feldman G. M., Finbloom D. S. Induction and regulation of IL-4 receptor expression on murine macrophage cell lines and bone marrow-derived macrophages by IFN-γ. J Immunol 1990; 145: 854–859
   PubMed Web of Science ®Google Scholar
• Feldman G. M., Ruhl S., Bickel M., et al. Regulation of interleukin-4 receptor on murine myeloid progenitor cells by interleukin-6. Blood 1991; 78: 1678–1684
   PubMed Web of Science ®Google Scholar
• Cabrillat H., Galizzi J-P, Djossou O., et al. High affinity binding of human interleukin 4 to cell lines. Biochem Biophys Res Commun 1987; 149: 995–1001
   PubMed Web of Science ®Google Scholar
• Okabe M., Kuni-Eda Y., Sugiwura T., et al. Inhibitory effects of IL-4 on the in vitro growth of Ph'-positive acute lymphoblastic leukemia cells. Blood, 78: 1574–1580
   PubMed Web of Science ®Google Scholar
• Puri R. K., Ogata M., Leland P., et al. Expression of high affinity IL4 receptors on murine sarcoma cells and receptor mediated cytotoxicity of tumor cells to chimeric protein between IL-4 and Pseudomonas exotoxin. Cancer Res 1991; 51: 3011–3017
   PubMed Web of Science ®Google Scholar
• Obiri N. I., Siegel J. P., Puri R. K. Expression of high affinity interleukin-4 receptors on human melanoma, ovarian and breast carcinoma cells, (submitted)
   Google Scholar
• Obiri N. I., Hillman G., Haas G., Sud S., Puri R. K. Expression of high affinity interleukin 4 receptors on human renal carcinoma cells and inhibition of tumor cell growth in vitro by IL-4. J Clin Invest 1993; 91: 88–93
   PubMed Web of Science ®Google Scholar
• Tüngekar M. F., Turley H., Dunnill M. S., et al. Interleukin-4 receptor expression on human lung tumors and normal lung. Cancer Res 1991; 51: 261–265
   PubMed Web of Science ®Google Scholar
• Galizzi J. P., Zuber C. E., Cabrillat H., et al. Internalization of human interleukin 4 receptor and transient downregulation of its receptor in the CD23-inducible jijoye cells. J Biol Chem 1989; 264: 6984–6989
   PubMed Web of Science ®Google Scholar
• Keegan A. D., Beckmann M. P., Park L. S., et al. The IL-4 receptor: Biochemical characterization of IL-4-binding molecules in a T cell line expressing large numbers of receptors. J Immunol 1991; 146: 2272–2279
   PubMed Web of Science ®Google Scholar
• Mosley B., Beckmann M. P., Park L. S., et al. The murine IL-4 receptor: Molecular cloning and characterization of secreted and membrane forms. Cell 1989; 59: 335–348
   PubMed Web of Science ®Google Scholar
• Harada N., Castle B. E., Gorman D. M., et al. Expression cloning of a cDNA encoding the murine IL-4 receptor based on ligand binding. Proc Natl Acad Sci USA 1990; 87: 857–861
   PubMed Web of Science ®Google Scholar
• Galizzi J-P, Zuber C. E., Harada N., et al. Molecular cloning of a cDNA encoding the human IL-4 receptor. Int Immunol 1990; 2: 669–675
   PubMed Web of Science ®Google Scholar
• Bazan J. F. Haemopoietic receptors and helical cytokines. Immunol Today 1990; 11: 350–356
   PubMedGoogle Scholar
• Ruhl S., Feldman G. M., Akahane K., et al. Soluble IL-4 receptor production by murine myeloid cells: Induction by IL-6 and IFN-γ. Cytokine 1993, (in press)
   PubMed Web of Science ®Google Scholar
• Fernandez-Botran R., Vitetta E. S. A soluble, high affinity, interleukin-4-binding protein is present in the biological fluids of mice. Proc Natl Acad Sci USA 1990; 87: 4202–4206
   PubMed Web of Science ®Google Scholar
• Fanslow W. C., Clifford K., Vanden Box T., et al. A soluble form of the IL-4 receptor in biological fluids. Cytokine 1990; 2: 298–301
   Google Scholar
• Jacobs C. A., Lynch D. H., Roux E. R., et al. Characterization and pharmacokinetics parameters of soluble Interleukin 4 receptor. Blood 1991; 7: 2396–2403
   Google Scholar
• Fanslow W. C., Clifford K. N., Rubin A. S., et al. Regulation of al-loreactivity in vivo by IL-4 and the soluble IL-4 receptor. J Immunol 1991; 147: 535–540
   PubMed Web of Science ®Google Scholar
• Bosco M., Giovarelli M., Forni M., et al. Low doses of IL4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J Immunol 1990; 145: 3136–3143
   PubMed Web of Science ®Google Scholar
• Tepper R. I., Pattengale P. K., Leder P. Murine Interleukin 4 displays potent antitumor activity in vivo. Cell 1989; 57: 503–512
   PubMed Web of Science ®Google Scholar
• Li W., Diamantstein T., Blakenstein T. Lack of tumorigenicity of intereleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4. Mol Immunol 1990; 27: 1331–1337
   PubMed Web of Science ®Google Scholar
• Golumbek P. T., Lazenby J. A., Levitsky H. I., et al. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 1991; 254: 713–716
   PubMed Web of Science ®Google Scholar
• Akashi K., Shibuya T., Harada M., et al. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells. J Clin Invest 1991; 88: 223–230
   PubMed Web of Science ®Google Scholar
• Luo H., Rubio M., Biron G., et al. Antiproliferative effect of interleukin-4 in B chronic lymhocytic leukemia. J Immunother 1991; 10: 418–425
   PubMed Web of Science ®Google Scholar
• Carlsson M., Sundstrom C., Bentsson M., et al. IL-4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals. Eur J Immunol 1989; 19: 913–21
   PubMed Web of Science ®Google Scholar
• Mahar D. W., Pike B. L., Boyd A. W. The response of human B cells to interleukin 4 is determined by their stage of activation and differentiation. Scand J Immunol 1990; 32: 631–640
   PubMed Web of Science ®Google Scholar
• Andreef F. HM, Gruss H-J, Brach M. A., et al. Interleukin-4 inhibits growth of multiple myelomas by suppressing IL-6 expression. Blood 1991; 78: 2070–2074
   PubMed Web of Science ®Google Scholar
• Taylor C. W., Grogan T. M., Salmon S. E. Effects of Interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms. Blood 1990; 75: 1114–1118
   PubMed Web of Science ®Google Scholar
• Defrance T., Fluciger A-C, Rossi J-F, et al. Antiproliferative effects of IL-4 on freshly isolated non-Hodgkin malignant B-lymphoma cells. Blood 1992; 79: 990–996
   PubMed Web of Science ®Google Scholar
• Tony H-P, Lehrnbecher T., Merz H., et al. Regulation of IL-4 responsiveness in lymphoma B cells. Leukemia Res 1991; 15: 911–919
   PubMed Web of Science ®Google Scholar
• Totpal K., Aggarwal B. B. Interleukin 4 potentiates the antipro-liferative effects of tumor necrosis factor on various tumor cell lines. Cancer Res 1991; 51: 4266–4270
   PubMed Web of Science ®Google Scholar
• Imai Y., Nara N., Tohda S., et al. Antiproliferative and differentiative effects of recombinant interleukin-4 on a G-CSF-stimulating-dependent tnyeloblastic leukemic cell line. Blood 1991; 78: 471–478
   PubMed Web of Science ®Google Scholar
• Al Jabaari B., Ladyman H. M., Larche M., et al. Elevated expression of the interleukin 4 receptor in carcinoma: A target for immunotherapy. Br J Cancer 1989; 59: 910–914
   PubMed Web of Science ®Google Scholar
• Hoon D. SB, Banex M., Okun E., et al. Modulation of human melanoma cells by interleukin-4 and in combination with γ-interferon or α-tumor necrosis factor. Cancer Res 1991; 51: 2002–2008
   PubMed Web of Science ®Google Scholar
• Hoon D. SB, Okun E., Banez M., et al. Interleukin 4 alone and with γ-interferon or tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas. Cancer Res 1991; 51: 5687–5693
   PubMed Web of Science ®Google Scholar
• Toi M., Bicknel R., Harris A. L. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res 1992; 52: 275–279
   PubMed Web of Science ®Google Scholar
• Ohara J. Interleukin 4: Molecular structure and biochemical characteristics, biological function and receptor expression. The Year in Immunology. Immunoregulatory Cytokines and Cell Growth, Vol 5, J. M. Cruse, R. E. Lewis, Jr. Karger, Basel 1989; 126–159
   Google Scholar
• Lotze M. T. In vivo administration of recombinant human interleukin 4 to patients with cancer. J Cell Biochem 1991; 33(Suppl F), (abstract)
   Google Scholar
• Markowitz A., Kleinerman E., Hudson M., et al. Phase I study of recombinant IL-4 in patients with advanced cancer. Blood 1989; 74(Suppl)146a, (abstract)
   Google Scholar
• Taylor C. W., Hultquist K. E., Taylo A. M., et al. Immunopharmacology of recombinant human interleukin-4 administered by the subcutaneous route in patients with malignancy. Blood 1992; 76(Suppl)221a, (abstract)
   Google Scholar
• Sosman J. A., Ellis T., Bodner B., et al. A phase IA/1B trial of continuous infusion interleukin-4 alone and following interleukin-2 in cancer patients. Proc Am Assoc Cancer Res 1992; 33: 2070, (abstract)
   Google Scholar
• Netaji B., Murphy S., Budd G. T., et al. Phase IA/IB trial of rIL-2 and rhuIL-4 in refractory malignancy. Proc Am Assoc Cancer Res 1991; 32: 1152, (abstract)
   Google Scholar
• Whitehead R. P., Friedman K. D., Clark D. A. A phase I trial of subcutaneous interleukin 2 and interleukin 4. Proc Am Assoc Cancer Res 1992; 33: 1381, (abstract)
   Google Scholar
• Freimann J., Estrov Z., Itoh K., et al. Phase I studies of recombinant interleukin-4 in patients with hematologic malignancies. Blood 1990; 76(Suppl)93a, (abstract)
   Google Scholar
• Maher D., Boyd A., McKendrick J., et al. Rapid response of B cell malignancies induced by interleukin 4. Blood 1990; 76(Suppl)152a, (abstract)
   Google Scholar